HU9700927D0 - Fluorinated vitamine d3 analogues - Google Patents

Fluorinated vitamine d3 analogues

Info

Publication number
HU9700927D0
HU9700927D0 HU9700927A HUP9700927A HU9700927D0 HU 9700927 D0 HU9700927 D0 HU 9700927D0 HU 9700927 A HU9700927 A HU 9700927A HU P9700927 A HUP9700927 A HU P9700927A HU 9700927 D0 HU9700927 D0 HU 9700927D0
Authority
HU
Hungary
Prior art keywords
vitamine
analogues
fluorinated
fluorinated vitamine
Prior art date
Application number
HU9700927A
Other languages
English (en)
Inventor
Bernard Michael Hennessy
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HU9700927D0 publication Critical patent/HU9700927D0/hu
Publication of HUP9700927A2 publication Critical patent/HUP9700927A2/hu
Publication of HUP9700927A3 publication Critical patent/HUP9700927A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU9700927A 1996-05-23 1997-05-21 Fluorinated vitamine d3 analogues and pharmaceutical compositions containing them HUP9700927A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1818796P 1996-05-23 1996-05-23

Publications (3)

Publication Number Publication Date
HU9700927D0 true HU9700927D0 (en) 1997-07-28
HUP9700927A2 HUP9700927A2 (hu) 1998-01-28
HUP9700927A3 HUP9700927A3 (en) 1999-07-28

Family

ID=21786696

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9700927A HUP9700927A3 (en) 1996-05-23 1997-05-21 Fluorinated vitamine d3 analogues and pharmaceutical compositions containing them

Country Status (30)

Country Link
US (1) US5888994A (hu)
EP (1) EP0808831B1 (hu)
JP (1) JP2858571B2 (hu)
KR (1) KR100237523B1 (hu)
CN (1) CN1081184C (hu)
AR (1) AR007240A1 (hu)
AT (1) ATE195514T1 (hu)
AU (1) AU720098B2 (hu)
BR (1) BR9703373A (hu)
CA (1) CA2204478C (hu)
CO (1) CO4840512A1 (hu)
CZ (1) CZ157997A3 (hu)
DE (1) DE69702812T2 (hu)
DK (1) DK0808831T3 (hu)
ES (1) ES2150719T3 (hu)
GR (1) GR3034832T3 (hu)
HR (1) HRP970274A2 (hu)
HU (1) HUP9700927A3 (hu)
IL (1) IL120842A0 (hu)
MA (1) MA24345A1 (hu)
NO (1) NO971934L (hu)
NZ (1) NZ314838A (hu)
PL (1) PL320131A1 (hu)
PT (1) PT808831E (hu)
SG (1) SG50831A1 (hu)
TR (1) TR199700418A2 (hu)
TW (1) TW374762B (hu)
UY (1) UY24563A1 (hu)
YU (1) YU19997A (hu)
ZA (1) ZA974334B (hu)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
AU744471B2 (en) * 1997-05-16 2002-02-21 Women & Infants Hospital 3-epi vitamin D2 compounds and uses thereof
WO1998051678A1 (en) * 1997-05-16 1998-11-19 Women & Infants Hospital CYCLIC ETHER VITAMIN D3 COMPOUNDS, 1α (OH) 3-EPI-VITAMIN D3 COMPOUNDS AND USES THEREOF
CA2303248A1 (en) * 1997-09-08 1999-03-18 F. Hoffmann-La Roche Ag 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
AU3390400A (en) * 1999-03-05 2000-09-21 Johns Hopkins University, The Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
EP1812011A1 (en) 2004-11-12 2007-08-01 Bioxell S.p.a. Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
EP3332788A1 (en) 2006-02-03 2018-06-13 Opko Renal, LLC Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
CA2655499C (en) 2006-06-21 2015-10-27 Proventiv Therapeutics, Llc Method of treating and preventing secondary hyperparathyroidism_with vitamin d repletion and vitamin d replacemnt therapies
PT2148684E (pt) 2007-04-25 2013-04-19 Cytochroma Inc Método de tratamento para a insuficiência e deficiência de vitamina d
HRP20231142T3 (hr) 2007-04-25 2024-01-05 Eirgen Pharma Ltd. Kontrolirano oslobađanje 25-hidroksivitamina d
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
US8754067B2 (en) 2010-11-12 2014-06-17 Wisconsin Alumni Research Foundation 22-haloacetoxy-homopregnacalciferol analogs and their uses
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
CN106604733A (zh) 2014-08-07 2017-04-26 欧普科爱尔兰环球控股有限公司 利用25‑羟基维生素d的辅助疗法
AU2017253821B2 (en) 2016-03-28 2022-11-03 Opko Ireland Global Holdings, Limited Methods of vitamin D treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5039671A (en) * 1984-12-19 1991-08-13 Hoffmann-La Roche Inc. Trifluorinated-1α,25S-dihydroxy vitamin D3 compounds
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US4804502A (en) * 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
GB9007236D0 (en) * 1990-03-30 1990-05-30 Leo Pharm Prod Ltd Chemical compounds
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
US5206230A (en) * 1991-06-05 1993-04-27 Daikin Industries, Ltd. Fluorine-containing vitamin D3 analogues and pharmaceutical composition containing the same
US5210237A (en) * 1991-08-27 1993-05-11 Daikin Industries, Ltd. Vitamin d3 analogues
US5200536A (en) * 1992-02-10 1993-04-06 Daikin Industries Ltd. Fluorine-containing vitamin D3 analogues
GB9206648D0 (en) * 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
EP0580968B1 (en) * 1992-05-20 1996-08-28 F. Hoffmann-La Roche Ag Vitamin D3 fluorinated analogs
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
TW267161B (hu) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger

Also Published As

Publication number Publication date
CN1081184C (zh) 2002-03-20
YU19997A (sh) 1999-07-28
HRP970274A2 (en) 1998-04-30
MX9703776A (es) 1998-06-30
KR970074763A (ko) 1997-12-10
TR199700418A3 (tr) 1997-12-21
PL320131A1 (en) 1997-11-24
CA2204478A1 (en) 1997-11-23
NZ314838A (en) 1998-01-26
UY24563A1 (es) 2000-12-29
KR100237523B1 (ko) 2000-01-15
NO971934L (no) 1997-11-24
EP0808831A2 (en) 1997-11-26
HUP9700927A2 (hu) 1998-01-28
MA24345A1 (fr) 1998-07-01
DE69702812T2 (de) 2001-01-25
ATE195514T1 (de) 2000-09-15
EP0808831B1 (en) 2000-08-16
CA2204478C (en) 2006-11-21
ZA974334B (en) 1997-11-24
AU2357297A (en) 1997-11-27
DK0808831T3 (da) 2001-01-02
CN1169425A (zh) 1998-01-07
DE69702812D1 (de) 2000-09-21
CO4840512A1 (es) 1999-09-27
SG50831A1 (en) 1998-07-20
GR3034832T3 (en) 2001-02-28
PT808831E (pt) 2000-12-29
IL120842A0 (en) 1997-09-30
BR9703373A (pt) 1998-09-15
ES2150719T3 (es) 2000-12-01
TR199700418A2 (xx) 1997-12-21
TW374762B (en) 1999-11-21
JP2858571B2 (ja) 1999-02-17
AU720098B2 (en) 2000-05-25
AR007240A1 (es) 1999-10-27
JPH1045712A (ja) 1998-02-17
CZ157997A3 (en) 1997-12-17
HUP9700927A3 (en) 1999-07-28
EP0808831A3 (en) 1999-02-03
US5888994A (en) 1999-03-30
NO971934D0 (no) 1997-04-25

Similar Documents

Publication Publication Date Title
HU9700926D0 (en) Vitamine d3 analogues
HK1043588A1 (en) Vitamin d analogues
GB9602028D0 (en) Nucleoside analogues
AU6590798A (en) Self contained breathing apparatus
HU9700927D0 (en) Fluorinated vitamine d3 analogues
EP0996458A4 (en) SANDRAMYCIN ANALOG
HU9700928D0 (en) Fluorinated vitamine d3 analogues
GB0030722D0 (en) Fluorinated terphenyls
HUT65350A (en) Fluorine-containing vitamin d3 analogues
ZA200304047B (en) Analogues of GLP-1.
GB9608180D0 (en) Phosphate analogues
GB9601685D0 (en) Fluorinated compounds
GB2309969B (en) Nucleoside analogues
ZA974332B (en) Fluorinated vitamin D3 analogs.
GB9500641D0 (en) Fluorinated compounds
SI1023263T1 (en) Novel vitamin d analogues
GB2309968B (en) Nucleoside analogues
CA79886S (en) Monitor
SG24096A1 (en) Fluorinated vitamin D3 derivative
GB9705198D0 (en) Plastisols
IL108662A0 (en) Stabilized platforms
IL118685A0 (en) Foot rest
HU9401780D0 (en) Orthoped shoe-sole
HU9401567D0 (en) Orthoped shoe-sole
AU135943S (en) Foot rest